 MINNEAPOLIS and LONDON, June 10, 2021 PRNewswire -- Bio-Techne Corporation NASDAQ: TECH, a leader in developing innovative tools and technologies for cell and gene therapy research and manufacturing, has partnered with Autolomous to implement a first of its kind electronic batch record system, AutoloMATETM, at Bio-Technes GMP cellular manufacturing center. Through this partnership Bio-Techne will be able to offer state of the art electronic records to therapeutic companies utilizing its non-viral gene delivery system, TcBusterTM, or contract cellular manufacturing services alongside working with Autolomous to integrate further its analytical and manufacturing technologies within their platforms. 